Belgium: Namsa expands reach with acquisition of Suazio

US-based medtech CRO, Namsa, has acquired Suazio, an Antwerp-based strategic consultancy providing global market research services to medical device and IVD developers. The acquisition was funded by PE healthcare investor, Archimed, which acquired Namsa in 2021 through its MED Platform I fund. Since then, Namsa has made seven acquisitions in Europe and the US and…

You must be a HMI Subscriber to view this content.

Subscribe Now »